⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1504634 | 0.67 | — | — | |
| SCHEMBL11416703 | 0.60 | — | — | |
| SCHEMBL205123 | 0.59 | — | — | |
| SCHEMBL2474911 | 0.59 | — | — | |
| SCHEMBL66538 | 0.59 | — | — | |
| SCHEMBL38382 | 0.59 | — | — | |
| SCHEMBL229347 | 0.59 | — | — | |
| SCHEMBL234303 | 0.59 | — | — | |
| SCHEMBL258389 | 0.59 | — | — | |
| SCHEMBL298780 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0938310-A4 | ANTI-VIRAL COMPOUNDS | LILLY CO ELI (US) | 2001-03-21 | — | — | EP | disclosed |
| EP-0906097-A4 | ANTI-VIRAL COMPOUNDS | LILLY CO ELI (US) | 2000-12-13 | — | — | EP | disclosed |
| EP-0938310-A1 | ANTI-VIRAL COMPOUNDS | ELI LILLY AND COMPANY (US) | 1999-09-01 | — | — | EP | disclosed |
| EP-0906097-A1 | ANTI-VIRAL COMPOUNDS | ELI LILLY AND COMPANY (US) | 1999-04-07 | — | — | EP | disclosed |
| WO-1997046235-A1 | ANTI-VIRAL COMPOUNDS | ELI LILLY AND COMPANY (US) | 1997-12-11 | — | — | WO | disclosed |
| WO-1997046237-A1 | ANTI-VIRAL COMPOUNDS | ELI LILLY AND COMPANY (US) | 1997-12-11 | — | — | WO | disclosed |